1. Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction
   Aysegul Durak et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
2. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
   Sho-ichi Yamagishi et al, 2015, Cardiovascular Diabetology CrossRef
3. Modulation of myocardial injury and collagen deposition following ischaemia–reperfusion by linagliptin and liraglutide, and both together
   Xianwei Wang et al, 2016, Clinical Science CrossRef
4. Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
   Samson Mathews Samuel et al, 2022, Biomolecules CrossRef
5. Myocardial glucotoxicity: Mechanisms and potential therapeutic targets
   Sylvain Battault et al, 2020, Archives of Cardiovascular Diseases CrossRef
6. Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis
   Song Chen et al, 2016, Neuroscience Letters CrossRef
7. Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide
   Cheng-Yen Tsai et al, 2015, International Journal of Cardiology CrossRef
8. Advanced Glycation End Products: New Clinical and Molecular Perspectives
   Juan Salazar et al, 2021, International Journal of Environmental Research and Public Health CrossRef
9. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
   Dilara Kiran et al, 2016, Seminars in Immunopathology CrossRef
10. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products
    Shuang-Shuang Zhang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
11. Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice
    Lin Zhu et al, 2014, Cardiovascular Diabetology CrossRef